Understanding the Emerging Threat of Hypervirulent Klebsiella pneumoniae

Klebsiella pneumoniae, a gram-negative bacterium, has emerged as a significant clinical and public health due to its capacity to induce severe and potentially life-threatening infections. This pathogen commonly targets individuals with compromised immune systems, including those undergoing chemotherapy or immunosuppressive therapy, as well as patients with underlying conditions such as diabetes mellitus or chronic obstructive pulmonary disease (COPD). Among the spectrum of infections attributed to K. pneumoniae, pneumonia, liver abscesses, soft tissue and surgical site infections, and sepsis represent significant clinical manifestations that can lead to substantial morbidity and mortality rates.

In recent years, a distinct variant of K. pneumoniae has emerged, a new frontier in infectious disease epidemiology: hypervirulent Klebsiella pneumoniae (hvKp). Originating from Taiwan in the 1980s, hvKp has since traversed geographical boundaries, precipitating sporadic outbreaks in various regions across Asia, Europe, and the Americas. Unlike its classical counterpart, hvKp possesses an augmented virulence repertoire, characterized by enhanced pathogenicity and an expanded clinical spectrum.

Distinguishing hvKp from classical K. pneumoniae strains involves multifaceted considerations, encompassing phenotypic, genotypic, and clinical dimensions. Notably, hvKp infections are associated with disproportionately higher rates of mortality and morbidity compared to classical strains. The underlying mechanisms driving this heightened pathogenicity are alterations in capsule polysaccharide composition and enhanced biofilm formation capacity.

One hallmark feature of hvKp is that it often spreads in the community, which is different from what we usually expect with Klebsiella infections happening mainly in hospital.. This shift in epidemiology underscores the potential for hvKp to afflict otherwise healthy individuals across a broad age spectrum. Furthermore, hvKp exhibits a remarkable capacity for metastatic dissemination, enabling the spread of infection to diverse anatomical sites within affected hosts. While liver abscesses are common with hvKp, it can also cause other serious infections like pneumonia, necrotizing fasciitis, eye infections, and meningitis.

Understanding the intricate interplay between host susceptibility factors, bacterial virulence determinants, and environmental influences is imperative for combating the threat posed by hvKp. From a clinical standpoint, early recognition and prompt initiation of appropriate therapy are paramount in mitigating the adverse outcomes associated with hvKp infections.

In conclusion, the emergence of hypervirulent Klebsiella pneumoniae represents a formidable challenge in infectious diseases, requiring concerted efforts from the scientific community, healthcare practitioners, and public health authorities alike.

While precursor virulence genes associated with this phenotype of HvKp have been identified, knowledge regarding their specific roles in promoting proliferation, enhancing invasiveness, and contributing to the severity of infections remains limited. Comprehensive research efforts are essential to uncover the wide spectrum of virulence factors employed by HvKp, including their immunomodulatory strategies

Reference:
Turton JF, Payne Z, Coward A, Hopkins KL, Turton JA, Doumith M, Woodford N. (2016). Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and 'non-hypervirulent' types ST147, ST15 and ST383. J Med Microbiol. 2018 Jan;67(1):118-128. https://doi.org/10.1099/jmm.0.000653. Epub 2017 Dec 5. PMID: 29205138.
Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, et al. (2009) Virulent Clones of Klebsiella pneumoniae: Identification and Evolutionary Scenario Based on Genomic and Phenotypic Characterization. PLoS ONE 4(3): e4982. doi:10.1371/journal.pone.0004982
Russo, T. A., & Marr, C. M. (2019). Hypervirulent Klebsiella pneumoniae. Clinical Microbiology Reviews, 32(3). https://doi.org/10.1128/cmr.00001-19
Russo, T. A., Olson, R., MacDonald, U., Beanan, J., & Davidson, B. A. (2015). Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infection and immunity, 83(8), 3325–3333. https://doi.org/10.1128/IAI.00430-15
Paczosa MK, Mecsas J. (2016). Klebsiella pneumoniae: going on the offense with a Strong Defense, Microbiol Mol Biol Rev 80:629 - 661. https://doi.org/10.1128/MMBR.00078-15.